Medicinal Products

BIONOLYTE G5 solution for infusion box of 1 vial (polyethyl) of 500 ml

Generic drug of the therapeutic class: Anesthesia, resuscitation, analgesics
active ingredients: Glucose + Electrolytes
laboratory: Fresenius Kabi France

Injection solution for IV infusion
All forms

Indication

Carbohydrate caloric intake.

Hydro-electrolytic equilibration,

Dehydration, whatever the cause.

Dosage BIONOLYTE G5 solution for infusion box of 1 vial (polyethyl) of 500 ml

Carbohydrate caloric intake.

Hydro-electrolytic equilibration,

Dehydration, whatever the cause.

Against indications

This medication is contraindicated in the following situations:

With heart failure decompensated,

With severe respiratory insufficiency,

With major hepatic insufficiency,

HyperkaliÃÂmie,

In combination with hyperkalaemic diuretics (see section Interactions with other medicinal products and other forms of interaction ).

The use of this drug is contraindicated in combination with angiotensin converting enzyme inhibitors and, by extrapolation, with angiotensin II receptor antagonists, tacrolimus (see section Interactions with other drugs). drugs and other forms of interaction ).

Side effects Bionolyte G5

Frequency not known (can not be estimated on the basis of available data):

Risk of edema due to hydrosodeal overload

Declaration of suspected undesirable effects

The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Healthcare professionals declare any suspected adverse effects via the national system of declaration: National Agency for the Safety of Medicines and Health Products (ANSM) and the Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article